An injection solution containing a non-nucleoside reverse transcriptase inhibitor and poly (lactide-co-glycolide)

摘要

The present invention relates to a pharmaceutical composition comprising an organic solvent, a copolymer which is a poly (lactide-co-glycolide) dissolved in an organic solvent, and a copolymer of an aromatic and a heterocyclic aromatic or aromatic and heterocyclic aromatic and aliphatic heterocyclic group, Wherein the composition comprises a pharmaceutically active ingredient that is a non-nucleoside inhibitor of a reverse transcriptase or an HIV integrase, wherein the content of the pharmaceutically active ingredient is from about 8% to about 25% by weight of the copolymer solution.